Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

被引：0
|
作者：
G Hofstetter
A Berger
E Schuster
A Wolf
G Hager
I Vergote
I Cadron
J Sehouli
E I Braicu
S Mahner
P Speiser
C Marth
A G Zeimet
H Ulmer
R Zeillinger
N Concin
机构：
[1] Innsbruck Medical University,Department of Gynecology and Obstetrics
[2] Molecular Oncology Group,Department of Obstetrics and Gynecology
[3] Medical University of Vienna,Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology
[4] Universitaire Ziekenhuzen Leuven,Department of Gynecology
[5] Katholieke Universiteit Leuven,Department of Gynecology and Gynecologic Oncology
[6] European Competence Center for Ovarian Cancer,Department of Medical Statistics
[7] Campus Virchow Klinikum,undefined
[8] Charité – Universitätsmedizin Berlin,undefined
[9] University Medical Center Hamburg-Eppendorf,undefined
[10] Informatics,undefined
[11] and Health Economics,undefined
[12] Innsbruck Medical University,undefined
来源：
British Journal of Cancer | 2011年 / 105卷
关键词：
ovarian cancer; delta133p53; p53 isoforms; p53; p73;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1593 / 1599
页数：6
相关论文
共 50 条
  • [1] Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
    Hofstetter, G.
    Berger, A.
    Schuster, E.
    Wolf, A.
    Hager, G.
    Vergote, I.
    Cadron, I.
    Sehouli, J.
    Braicu, E. I.
    Mahner, S.
    Speiser, P.
    Marth, C.
    Zeimet, A. G.
    Ulmer, H.
    Zeillinger, R.
    Concin, N.
    BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1593 - 1599
  • [2] The Δ133p53 Isoforms, Tuners of the p53 Pathway
    Joruiz, Sebastien M.
    Beck, Jessica A.
    Horikawa, Izumi
    Harris, Curtis C.
    CANCERS, 2020, 12 (11) : 1 - 20
  • [3] The new p53 splice variants p53δ as independent prognostic marker in ovarian carcinoma
    Hofstetter, G.
    Schuster, E.
    Berger, A.
    Wolf, A.
    Marth, C.
    Zeimet, A.
    Concin, N.
    Zeillinger, R.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (05) : 460 - 461
  • [4] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    Hofstetter, G.
    Berger, A.
    Fiegl, H.
    Slade, N.
    Zoric, A.
    Holzer, B.
    Schuster, E.
    Mobus, V. J.
    Reimer, D.
    Daxenbichler, G.
    Marth, C.
    Zeimet, A. G.
    Concin, N.
    Zeillinger, R.
    ONCOGENE, 2010, 29 (13) : 1997 - 2004
  • [5] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    G Hofstetter
    A Berger
    H Fiegl
    N Slade
    A Zorić
    B Holzer
    E Schuster
    V J Mobus
    D Reimer
    G Daxenbichler
    C Marth
    A G Zeimet
    N Concin
    R Zeillinger
    Oncogene, 2010, 29 : 1997 - 2004
  • [6] The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
    Arsic, Nikola
    Gadea, Gilles
    Lagerqvist, E. Louise
    Busson, Muriel
    Cahuzac, Nathalie
    Brock, Carsten
    Hollande, Frederic
    Gire, Veronique
    Pannequin, Julie
    Roux, Pierre
    STEM CELL REPORTS, 2015, 4 (04): : 531 - 540
  • [7] p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
    Kaori Fujita
    Abdul M. Mondal
    Izumi Horikawa
    Giang H. Nguyen
    Kensuke Kumamoto
    Jane J. Sohn
    Elise D. Bowman
    Ewy A. Mathe
    Aaron J. Schetter
    Sharon R. Pine
    Helen Ji
    Borivoj Vojtesek
    Jean-Christophe Bourdon
    David P. Lane
    Curtis C. Harris
    Nature Cell Biology, 2009, 11 : 1135 - 1142
  • [8] p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
    Fujita, Kaori
    Mondal, Abdul M.
    Horikawa, Izumi
    Nguyen, Giang H.
    Kumamoto, Kensuke
    Sohn, Jane J.
    Bowman, Elise D.
    Mathe, Ewy A.
    Schetter, Aaron J.
    Pine, Sharon R.
    Ji, Helen
    Vojtesek, Borivoj
    Bourdon, Jean-Christophe
    Lane, David P.
    Harris, Curtis C.
    NATURE CELL BIOLOGY, 2009, 11 (09) : 1135 - U208
  • [9] p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
    Fujita, Kaori
    Mondal, Abdul M.
    Horikawa, Izumi
    Nguyen, Giang H.
    Kumamoto, Kensuke
    Sohn, Jane J.
    Bowman, Elise D.
    Mathe, A. Mathe
    Schetter, Aaron J.
    Pine, Sharon R.
    Ji, Helen
    Vojtesek, Borivoj
    Bourdon, Jean-Christophe
    Lane, David P.
    Harris, Curtis C.
    CANCER RESEARCH, 2010, 70
  • [10] IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER
    Heinzl, Nicole
    Maritschnegg, Elisabeth
    Koziel, Katarzyna
    Wilson, Stuart
    Heinze, Georg
    Wallisch, Christine
    Horvat, Reinhard
    Sehouli, Jalid
    Braicu, Ioana
    Vergote, Ignace
    van Nieuwenhuysen, Els
    Mahner, Sven
    Obermayr, Eva
    Schuster, Eva
    Holzer, Barbara
    Concin, Nicole
    Zeillinger, Robert
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 76 - 76
12345